An immunohistochemical evaluation of progesterone receptor in frozen sections, paraffin sections, and cytologic imprints of breast carcinomas.
Author(s): Ozzello L, DeRosa C, Habif DV, Greene GL
Publication: Cancer, 1991, Vol. 67, Page 455-62
PubMed ID: 1845948 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine the effects of fixative, and duration and temperature of fixation on ER and PR immunostaining results using frozen and fixed paraffin embedded specimens as well as stored cryostat sections and imprints of breast cancer specimens.
Summary of Findings:
ER IHC staining of paraffin-embedded specimens yielded the best results with short fixations of 1-2 hours in formalin at 4 degrees C or in Bouin's solution at room temperature. A fixation time of 24 hours in formalin or Bouin's resulted in some nonspecific cytoplasmic staining, except in formalin at 4 degrees C. PR immunostaining was good in imprints and cryostat sections stored at -80 degrees C when they were fixed in Zamboni's before freezing. Concordance rates between PR and ER immunostaining of frozen and paraffin sections were 85.4 and 93.6%, respectively. The authors said it was difficult to determine which preservation technique gave the most accurate results. Concordance rates between PR and ER immunostaining of preparations stored for up to 56 weeks and frozen sections were each 92.9%. Coating of imprints and cryostat sections with 6% polyethylene glycol during storage impaired immunoreactivity.
Biospecimens
Preservative Types
- Formalin
- Other Preservative
- Frozen
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation Bouin's fixative
Formalin (buffered)
Frozen
Zamboni's solution
Immunohistochemistry Specific Targeted peptide/protein ER
PR
Biospecimen Aliquots and Components Cell capture method Cryostat section
Imprint
Paraffin section
Biospecimen Preservation Temperature of fixation/preservation Room temperature
4 degrees C
Biospecimen Preservation Time in fixative 10 min
30 min
1 h
2 h
4 h
24 h
Storage Storage duration None
Up to 56 weeks
Storage Storage conditions Coated with 6% polyethylene glycol
Uncoated
-
Study Purpose
The purpose of this study was to determine the effects of antibody type and to compare immunoassay results with IHC staining results for differently preserved breast cancer specimens.
Summary of Findings:
When used at different optimal concentrations, PR antibodies JZB39 and KD68 worked well for fresh or stored frozen sections, paraffin sections, and imprints, regardless of preservation method, and gave concordant results 96.1% of the time. Immunostaining heterogeneity was seen for both antibodies in all specimens. Overall, more ER+ and/or PR+ cases were identified by IHC staining than by the DCCA for both pre- and postmenopausal women. Concordance rates for PR results between the two assays for frozen sections, paraffin sections, and stored preparations were 77.2, 80.8, and 76.8%, respectively (p<0.0005). Concordance rates for ER results between the two assays for frozen sections, paraffin sections, and stored preparations were 91.4, 87.3, and 78.6%, respectively.
Biospecimens
Preservative Types
- Formalin
- Other Preservative
- Frozen
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry Protein Immunoassay Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Immunohistochemistry Specific Targeted peptide/protein ER
PR
Immunohistochemistry Specific Type of antibody JZB39
KD68
H222
D75P3gamma
Immunoassay Specific Targeted peptide/protein ER
PR
Biospecimen Preservation Type of fixation/preservation Bouin's fixative
Formalin (buffered)
Frozen
Zamboni's solution
Biospecimen Aliquots and Components Cell capture method Cryostat section
Imprint
Paraffin section
Immunohistochemistry Specific Technology platform Immunoassay
Preaquisition Patient age Premenopausal
Postmenopausal
